SFDA issues Guiding Opinions on Enhancing the Construction of Adverse Drug Reaction Monitoring System

To implement the relevant requirements of the reform of the medical and health care system, further improve the adverse drug reaction reporting and monitoring system, improve the capability of monitor

The 2nd International Forum on Rapid Drug Testing & 3rd China-US Joint Symposium on Pharmaceutical Analytical Technology & Compendial Methods held in Hangzhou

On November 15-16, 2011, the 2nd International Forum on Rapid Drug Testing & 3rd China-US Joint Symposium on Pharmaceutical Analytical Technology & Compendial Methods, jointly organized by the

Study reveals principal mechanism of action for paracetamol

Researchers at King's College London have discovered how one of the most common household painkillers works, which could pave the way for less harmful pain relief medications to be developed in the fu

Merck settles Vioxx lawsuit in the US

Merck has agreed to pay a $950m fine to settle criminal and civil charges that it misrepresented the safety of its anti-inflammatory drug Vioxx. Under civil settlement agreements signed with the US a

Indian supreme court slams drug prices

The Supreme Court of India has informed the country's central government that drug prices are too high and should not be raised again. The criticism came during a Public Interest Litigation hearing,

Merck agrees to pay $950 million in Vioxx safety probe

By Dr Ananya Mandal, MD Merck & Co. will pay $950 million and one of its units will plead guilty to a criminal charge to resolve a U.S. probe of its illegal marketing of the painkiller Vioxx.

Report highlights rising use of mental health medications in US

A report from Medco Health Solutions revealed that more than one in five adult Americans took at least one medication to treat a psychiatric or behavioural disorder in 2010. 'America's State of Mind'

Viewpoints: Finding savings in Medicare; The Avastin saga; Changes in health care business

The New York Times: Fixing Medicare There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of olde

The 16th Asian Harmonization Working Party (AHWP) Meeting was held in Denpasar, Indonesia, on November 8-11, 2011. Directors and relevant officials of the Department of Medical Device Supervision and the Department of International Cooperation of the State Food and Drug Administration of China, representatives from the medical device regulatory bodies and enterprises of more than 20 member economies, as well as experts and scholars from the USA, EU, Japan, Australia and WHO, totaling more than 300 people, attended the meeting.

The 16th Asian Harmonization Working Party (AHWP) Meeting was held in Denpasar, Indonesia, on November 8-11, 2011. Directors and relevant officials of the Department of Medical Device Supervision and

Bristol-Myers Squibb and Pfizer report apixaban trial results

Bristol-Myers Squibb and Pfizer have presented the results of the Phase III trial to compare apixaban (Eliquis) to enoxaparin in acutely ill medical patients. In the study, patients randomised to api